Amarin Decision Opens Door To Longer Exclusivity Periods
On May 28, 2015, the U.S. District Court for the District of Columbia vacated and remanded the U.S. Food and Drug Administration's administrative decision denying five years of new chemical entity...To view the full article, register now.
Already a subscriber? Click here to view full article